Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avery Biomedical Devices is a medical technology company specializing in the development and manufacture of diaphragm pacing systems. Their primary product, the Avery Diaphragm Pacing System, is an implanted phrenic nerve stimulator designed to provide ventilatory support for patients with chronic respiratory insufficiency. This system is used for individuals with spinal cord injuries, central alveolar hypoventilation, and other conditions causing diaphragm paralysis. The company's technology aims to improve the quality of life by reducing or eliminating the need for mechanical ventilation. Avery Biomedical Devices is recognized for having the only diaphragm pacing system with pre-market approval (PMA) from the FDA for both adult and pediatric use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avery Biomedical Devices.